A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

This trial is investigating OCU410, a novel gene therapy designed as a one-time treatment for geographic atrophy (GA) caused by dry age-related macular degeneration (dAMD). The DSMB reviewed data ...

Age-related macular degeneration (AMD ... As of 2023, the only FDA-approved treatments for dry AMD are two injectable drugs. These treatments are constrained by potential complications from ...

Seeing may be believing, but this scientific breakthrough ... related macular degeneration affecting over 2 million people solely in the United States. A diagram of a healthy macula, dry macular ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

University of California San Diego researchers have identified a U-shaped association between high-density lipoprotein (HDL) ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no ...

Currently, there are no effective long-term treatments for GA ... secondary to dry age-related macular degeneration (dAMD). “The DSMB assessed data on 15 subjects from Phase 2.